| NAME |
ACTIVES |
STRENGTH |
PACK |
 |
| Cefim
Capsules |
Cefixime |
200
mg / 400 mg |
Blister
3's |
| Cefim
Suspension |
Cefixime |
100
mg / 5 ml |
Bottle
60 ml |
| Clariva
Tablets |
Clarithromycin |
250
mg / 500 mg |
Blister
14's & 7's |
| Cefovex Tablets |
Cefuroxime |
250
mg / 500 mg |
Blister
5's |
| Cefaclor
Capsules |
Cefaclor |
250
mg / 500 mg |
Blister 3's |
| Cefidur
Suspension |
Cefadroxil |
125
mg / 5 ml |
Bottle
100 ml |
| Cefotaxime
For Injection |
Cefotaxime
Sodium |
500
mg / 1 gm |
Vial |
| Ceftazidime For
Injection |
Ceftazidime
Sodium |
500
mg / 1 gm |
Vial |
| Ceftriaxone For
Injection |
Ceftriaxone
Sodium |
500
mg / 1 gm |
Vial |
| Cefovex Injection |
Cefuroxime
Sodium |
750
mg / 1.5 gm |
Vial |
| Cefovex
Suspension |
Cefuroxime |
125
mg / 5 ml |
Bottle
100 ml |
| Ciprozyn Tablets |
Ciprofloxacin |
250
mg / 500 mg |
Blister
10's |
| Cloxacillin
Capsules |
Cloxacillin |
250
mg / 500 mg |
Strip
10's, Jar 1000's |
| Cloxacillin
For Suspension |
Cloxacillin |
125
mg / 5 ml; 250 mg / 5ml |
Bottle
100 ml |
| Co-trimoxazole
Tablets |
Co-trimoxazole |
480
mg / 960 mg |
Blister 10's, Jar 1000's |
| Doxycycline
Capsules |
Doxycycline |
100
mg |
Blister
10's, Jar 1000's |
| Erythromycin
For Suspension |
Erythromycin |
125
mg / 5 ml |
Bottle
100 ml |
| Erythromycin
Tablets |
Erythromycin |
250
mg / 500 mg |
Blister 10's, Jar 1000's |
| Novirax
Tablets |
Acyclovir |
200
mg / 400 mg / 800 mg |
Blister
5's, Jar 360's |
| Terbinafine
Tablets |
Terbinafine |
125
mg / 250 mg |
Blister
14's |
|
| |
| |
| * |
Green colour indicates currently marketed products; Blue colour indicates proposed
products in R & D and registration. |
| * |
The pharmaceutical products will
be offered as per USP, BP or Ph. Eur. specifications as applicable. |
| * |
Oman Pharmaceutical Products Co. L.L.C., respects all patent laws and conventions on pharmaceuticals as applicable in different countries of the world. |
| * |
Products covered by
patents are not offered to countries where the patent law is in force.
However the final responsibility lies with the buyer. |
|
|
| |
|
|